Cardioversion of atrial fibrillation with ibutilide: When is it most effective?

Clinical Cardiology

Volumn 25, Issue 9, 2002, Pages 411-415

  Das, Mithilesh Kumar ^a   Cheriparambil, Kuruvilla ^a   Bedi, Ashwini ^b   Kassotis, John ^b   Reddy, Chatla V R ^b   Saul, Barry ^b   Makan, Majesh ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Atrial fibrillation; Ibutilide

Indexed keywords

IBUTILIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HIGH RISK POPULATION; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MORBIDITY; SINUS RHYTHM; TREATMENT OUTCOME; UNITED STATES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RISK FACTORS; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036727039     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960250904     Document Type: Article

References (40)

1. The management of atrial fibrillation
2. Atrial fibrillation in the elderly
3. Epidemiology and mechanism of atrial fibrillation and atrial flutter
4. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide
5. Coronary heart diseases and atrial fibrillation: The Framingham study
6. Atrial fibrillation follow-up investigation of rhythm management-The AFFIRM study design
7. The treatment of atrial fibrillation: Pharmacologic strategies
8. Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats
9. Electrophysiological remodeling of the heart owing to rate
10. Management of atrial fibrillation: Therapeutic options and clinical decisions
11. Restoration of sinus rhythm in patients with atrial fibrillation
12. Atrial fibrillation: A review of pathophysiology
13. Acute treatment of atrial fibrillation: Why and when to maintain sinus rhythm
14. What to do with acute atrial fibrillation?
15. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation
16. Ibutilide: A new class III antiarrhyhmic agent
17. Ibutilide
18. New advances in class III antiarrhythmic drug therapy
19. Effects of Class III drugs on atrial fibrillation
20. Ibutilide: An antiarrhythmic agent for the treatment of atrial fibrillation or flutter
21. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter
22. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm
23. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
24. Antiarmythmic drugs: A reorientation in light of recent developments in the control of disorders of rhythm
25. Ibutilide: A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation
26. kr) in AT-I cells
27. Treatment strategies for atrial fibrillation
28. Acute treatment of atrial fibrillation
29. Efficacy of ibutilide for termination of atrial fibrillation and flutter
30. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: Part 2
31. Nonpharmacologic strategies for treating atrial fibrillation
32. Current strategies for managing atrial fibrillation
33. Acute treatment of atrial fibrillation and flutter
34. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
35. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter
36. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization
37. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery
38. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter
39. Management and prevention of atrial fibrillation after cardiovascular surgery
40. Ibutilide: Efficacy and safety in atrial fibrillation and atrial flutter in general cardiology practice